This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.
PRESS RELEASE from provider: Business Wire
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.

Global Hernia Repair Devices Pipeline Assessment 2019 by Stage of Development, Segment, Territory, Regulatory Path, Estimated Approval Date & Ongoing Clinical Trials - ResearchAndMarkets.com

February 28, 2019

DUBLIN--(BUSINESS WIRE)--Feb 28, 2019--The “Hernia Repair Devices - Medical Devices Pipeline Assessment, 2019” report has been added to ResearchAndMarkets.com’s offering.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hernia Repair Devices pipeline products.


  • Extensive coverage of the Hernia Repair Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Hernia Repair Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Hernia Repair Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date.

Key Topics Covered:

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Hernia Repair Devices Overview

3 Products under Development

3.1 Hernia Repair Devices - Pipeline Products by Stage of Development

3.2 Hernia Repair Devices - Pipeline Products by Segment

3.3 Hernia Repair Devices - Pipeline Products by Territory

3.4 Hernia Repair Devices - Pipeline Products by Regulatory Path

3.5 Hernia Repair Devices - Pipeline Products by Estimated Approval Date

3.6 Hernia Repair Devices - Ongoing Clinical Trials

4 Hernia Repair Devices - Pipeline Products under Development by Companies

4.1 Hernia Repair Devices Companies - Pipeline Products by Stage of Development

4.2 Hernia Repair Devices - Pipeline Products by Stage of Development

5 Hernia Repair Devices Companies and Product Overview

5.1 Acera Surgical, Inc. Company Overview

5.2 Advanced Medical Solutions Group plc Company Overview

5.3 Aran Biomedical Company Overview

5.4 Ariste Medical LLC Company Overview

5.5 ArTack Medical Ltd Company Overview

5.6 Atrium Medical Corp Company Overview

5.7 Biorez Inc Company Overview

5.8 Cleveland Clinic Hospital Company Overview

5.9 Cousin Biotech Sarl Company Overview

5.10 CyndRX LLC Company Overview

5.11 Cytograft Tissue Engineering Inc (Inactive) Company Overview

5.12 Deep Blue Medical Advances Inc Company Overview

5.13 DSM Biomedical BV Company Overview

5.14 Kerecis ehf Company Overview

5.15 LifeBond Ltd Company Overview

5.16 LifeCell Corp Company Overview

5.17 Medprin Regenerative Medical Technologies Co Ltd Company Overview

5.18 MicroPort Scientific Corp Company Overview

5.19 Montana State University Company Overview

5.20 Nanovis Inc Company Overview

5.21 Orthocell Ltd Company Overview

5.22 Paradigm Surgical Devices LLC Company Overview

5.23 University of Colorado Company Overview

5.24 Via Surgical Ltd Company Overview

6 Hernia Repair Devices- Recent Developments

6.1 Jul 06, 2018: Shanghai MicroPort Medical (Group) Won a Patent Right Lawsuit Against NewMed Medical

6.2 Jun 28, 2018: Baxter Releases 2017 Corporate Responsibility Report and Reinforces Its Commitment to Enriching Communities Around the World

6.3 Jun 27, 2018: MicroPort Hosts the Sixth Science and Technology Conference

6.4 Jun 21, 2018: MicroPort Scientific Announces Change Of Non-Executive Director

6.5 Jun 07, 2018: TELA Bio Announces Initial Data from BRAVO Study of OviTex Reinforced BioScaffolds for Ventral Hernia Repair

6.6 Jun 06, 2018: Admedus Announces Conclusion Of Relationship With Go Medical

6.7 Jun 06, 2018: Advanced Medical Solutions announces retirement of CFO

6.8 May 23, 2018: Admedus Announce Appointment of Catherine Costello

6.9 May 21, 2018: Baxter Highlights Business Strategies and Innovation at 2018 Investor Conference

6.10 May 17, 2018: Mr. Jonathan Chen Promoted to Chief International Business Officer of MPSC

6.11 May 01, 2018: Admedus Names Michael Oswell As Vice President, Development

6.12 Apr 30, 2018: Admedus: Quarterly report - Appendix 4C for the period to 31 March 2018

6.13 Apr 26, 2018: Baxter Reports First-Quarter 2018 Results And Increases Financial Outlook For Full-Year 2018

6.14 Mar 28, 2018: MicroPort Scientific Announces 2017 Annual Results

6.15 Mar 27, 2018: MicroPort Scientific Announces Year Ended 31 December 2017 Financial Results

6.16 Mar 14, 2018: Advanced Medical Solutions Group: Unaudited Preliminary Results for the year ended 31 December 2017

6.17 Mar 13, 2018: Surgical Innovations Group: Final results for the year ended 31 December 2017

6.18 Mar 12, 2018: TELA Bio Announces Results from Retrospective Study of OviTex Reinforced BioScaffolds for Abdominal Wall Reconstruction

6.19 Feb 28, 2018: Admedus Financial Results For The Period Ended 31 December 2017

6.20 Feb 27, 2018: Admedus: Resignation / Appointment of Company Secretary and Change of Registered Office

7 Appendix

For more information about this report visit https://www.researchandmarkets.com/research/7z538p/global_hernia?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190228005359/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Medical Devices



SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 02/28/2019 04:37 AM/DISC: 02/28/2019 04:37 AM